Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May:68:100954.
doi: 10.1016/j.drup.2023.100954. Epub 2023 Mar 1.

Antimicrobial peptides for combating drug-resistant bacterial infections

Affiliations
Free article
Review

Antimicrobial peptides for combating drug-resistant bacterial infections

Jiaqi Xuan et al. Drug Resist Updat. 2023 May.
Free article

Abstract

The problem of drug resistance due to long-term use of antibiotics has been a concern for years. As this problem grows worse, infections caused by multiple bacteria are expanding rapidly and are extremely detrimental to human health. Antimicrobial peptides (AMPs) are a good alternative to current antimicrobials with potent antimicrobial activity and unique antimicrobial mechanisms, which have advantages over traditional antibiotics in fighting against drug-resistant bacterial infections. Currently, researchers have conducted clinical investigations on AMPs for drug-resistant bacterial infections while integrating new technologies in the development of AMPs, such as changing amino acid structure of AMPs and using different delivery methods for AMPs. This article introduces the basic properties of AMPs, deliberates the mechanism of drug resistance in bacteria and the therapeutic mechanism of AMPs. The current disadvantages and advances of AMPs in combating drug-resistant bacterial infections are also discussed. This article provides important insights into the research and clinical application of new AMPs for drug-resistant bacterial infections.

Keywords: Antibiotics; Antimicrobial peptides; Bacterial infection; Drug resistance.

PubMed Disclaimer

Conflict of interest statement

Competing Interests Authors declare that they have no conflict of interest.

Publication types

MeSH terms

Substances